Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.8500 (0.8%) ($13.8500 - $13.8500) on Tue. Apr. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 39 | Latest Price | $13.8500(0.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -2% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(44%) IBB(44%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.335% in a week (0% probabilities). VIXM(-35%) VXX(-26%) UNG(-11%) TLT(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.54(-67.22%) | Resistance Level | $14.61 | 5 Day Moving Average | $13.95(-0.72%) | 10 Day Moving Average | $14.2(-2.46%) | 20 Day Moving Average | $14.61(-5.2%) | To recent high | -33.1% | To recent low | 0.8% | Market Cap | $1.029b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |